a subclone of HeLa.S3 cells provided by Dr. Mikoshiba in 2009.
Terms and conditions
1) The RECIPIENT should obtain written approval from the DEPOSITOR using the APPROVAL FORM prior to entering the AGREEMENT with the RIKEN BRC. 2) A RECIPIENT who belongs to a non-profit organization may use the BIOLOGICAL RESOURCE for an academic research that is non-commercial. 3) In publishing the research results related to the BIOLOGICAL RESOURCE, a citation of the following literature is necessary. (bioRxiv 2020 March 31, 2020 ). 4) The RECIPIENT agrees to acknowledge the DEPOSITOR in any publication, oral or written, reporting use of the BIOLOGICAL RESOURCE and provide a copy of the publication to the DEPOSITOR.
RIKEN Center for Brain Science Laboratory for Cell Function Dynamics Hirosawa 2-1, Wako, Saitama 351-0198 Japan
Fax. +81-48-467-5924 E-mail. email@example.com
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (firstname.lastname@example.org).
Ando R, Sakaue-Sawano A, Shoda K, Miyawaki A.
Two coral fluorescent proteins of distinct colors for sharp visualization of cell-cycle progressionCell Struct Funct
PubMed ID: 37394513
Tohyama K, Kaida A, Miura M.
Determination of Clonogenic Radiosensitivity of HeLa Cells in Early and Late G1 PhasesAnticancer Res
PubMed ID: 36288874
Shimono H, Kaida A, Homma H, Nojima H, Onozato Y, Harada H, Miura M.
Fluctuation in radioresponse of HeLa cells during the cell cycle evaluated based on micronucleus frequency.Sci Rep
PubMed ID: 33257719